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ORIGINAL ARTICLE  
LAPAROSCOPIC SLEEVE GASTRECTOMY – A PROSPECTIVE 
FOLLOW UP OF 30 PATIENTS 
Asad Ali Toor, Muhammad Waris Farooka*, Mahmood Ayyaz*, Zeeshan Razzaq, Awais Amjad Malik*, 
Allah Nawaz*, Asif Mahmood*, Henry Paul Redmond 
Department of Surgery, Cork University Hospital, Wilton, County Cork-Republic of Ireland, *Department of General Surgery, National 
Hospital & Medical Centre, Lahore-Pakistan 
Background: Morbid obesity has become a surgically treatable problem. Laparoscopic sleeve 
gastrectomy is becoming a popular choice both for surgeons and patients due to effectiveness and 
low complication rates. Methods: It was a prospective case series spanning over 6 years. Patient 
enrolment started from January 2009 and data collection completed in January 2015. Patient with 
BMI (weight in kilogram/height in meter square) of more than 35 were included in the study. 
Follow up was at 2 weeks, 1 month, 6 months and 12 months. Success was defined as 25% of 
excess weight loss at 1 year. Paired t-test was used as a test of significance. Results: A total of 34 
patients were included in the study over a 6-year period, 3 were lost to follow up and one patient 
died of cardiac arrest. Data of 30 patients is considered for final analysis. Mean age was 39.5±10 
years, while mean BMI 45.8±6.3 (range 37.1–62.2). Average weight of the patients pre-
operatively was 129.9±20.8 kg while mean excess weight was 70.3±20.8 kg. Average weight loss 
at two weeks was 8.9±2.9 kg, at one month 14.7±4.6 kg, at 6 months 25.0±7.6 kg and at twelve 
months was 31.4±6.8 kg. Mean percentage of excess weight loss after 2 weeks was 13.5±4.6%, at 
one month 22.0±6.1%, at six months 37.6±12.0% and at twelve months 47.3±10.1%. Conclusion: 
Laparoscopic sleeve gastrectomy is an effective weight loss surgery with minimal complications. 
On average weight loss of about 30 kg at one year was achieved which equals to almost half of 
excess body weight. 
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INTRODUCTION 
Morbid obesity has become a surgically treatable 
problem.1 Recent data showed surgical management 
for morbid obesity is successful when diet and 
medical therapy are unsuccessful.2 Laparoscopy 
made obesity surgery more safe and acceptable to 
patients.3 Metabolic surgery is the name assigned to 
surgery for treatment of obesity and conditions for 
which obesity is a cause or contributing factor.4–6  
A wide range of weight loss surgical 
procedures are available, most popular procedures 
include Adjustable Gastric Banding, Sleeve 
Gastrectomy and Roux-en-Y Gastric Bypass. Roux-
en-Y Gastric bypass is a procedure in which calorie 
absorption in restricted.7 Adjustable gastric banding 
and sleeve gastrectomy are restrictive procedures 
which aim at reducing food intake.8 Sleeve 
gastrectomy is an efficient procedure for patients 
with super obesity (BMI>50 kg/m2) and super obesity 
(BMI>60 kg/m2).9  
Obesity is associated with development of 
type 2 diabetes mellitus, hyperlipidaemia, coronary 
artery disease, sleep apnoea, osteoarthritis and 
increased risk of some cancers.10 All obesity related 
co-morbidities put people at increased risk of 
morbidity and mortality. Almost 44% of the diabetes 
burden, 23% of the ischemic heart disease burden and 
between 7–41% of certain cancers are attributed to 
overweight and obesity.11  
Weight loss surgery is performed as a single 
procedure or a succession of procedures. Usually 
sleeve gastrectomy is first step in high risk patient 
where initial weight reduction is achieved to perform 
more complex Roux-en-Y Gastric Bypass surgery.12 
Both procedures are safe and effective in loosing 
excess body weight.13,14 But later studies showed that 
both Sleeve gastrectomy and Roux-en-Y Gastric 
Bypass surgery are equally effective.15 This led to the 
idea of sleeve gastrectomy as a standalone procedure 
for treatment of morbid obesity.16 Sleeve gastrectomy 
results in excess weight loss and remission of co-
morbidities comparable with other procedures.9,17 
This study was designed to measure weight 
loss after sleeve gastrectomy at 1 year in Pakistani 
population.  
MATERIAL AND METHODS 
It was a prospective case series spanning over 6 
years. Patient enrolment started from January 2009 
and data collection completed in January 2015. All 
consecutive patients who were admitted for 
laparoscopic sleeve gastrectomy were included in this 
study. This study was conducted at National Hospital 
& Medical Centre, Lahore, Pakistan. Patients were 
with BMI (weight in kilogram (kg) /(m2) height in 
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meter square) of more than 35 who wanted to reduce 
weight by surgery were included in this study. 
Patients were operated after getting fitness for 
anaesthesia was by a consultant anaesthetist. Patients 
were given all details of the procedure, procedure 
was explained by diagrams and possible 
complications explained. Informed consent was 
obtained from the patients and ethical approval 
obtained from hospital ethical review committee. All 
data of the patients was recorded on pre-designed 
Performa during admission, on each visit in 
outpatient up to 1 year after surgery. Pre-operatively 
all patients had baseline investigations including 
complete blood count, blood urea, coagulation 
profile, serum Creatinine, random blood sugar levels 
in case of known diabetic patients HbA1c levels, liver 
enzymes levels, fasting lipid profile, thyroid function 
tests, chest radiograph, ultrasound of abdomen and 
pulmonary function tests where indicated. All 
patients were assessed by consultant Endocrinologist 
for diabetes mellitus, hypertension and thyroid 
abnormalities and treatment initiated. All patients 
were assessed by nutritionist for diet control pre-
operatively. All patients received written instruction 
on restarting diet after surgical procedure. Post-
operatively all patients were kept for 24 hours in 
recovery for monitoring and pain control. Deep 
venous thrombosis prophylaxis was started within 24 
hours after surgery. 
Pneumoperitoneum was created by opti 
view port, 2 inches above and one inch left to 
umbilicus. Mostly 15-18mmHg of intra-abdominal 
pressure was maintained during procedure. Two 12 
mm working ports introduced in both mid-
clavicular lines 1 inch above opti view port. One 
5mm port for liver retraction in epigastric region 
and another 5mm assistant port in anterior axillary 
line on left side, as shown in figure-1. 
Laparoscope was introduced through 
supra-umbilical port and thorough abdominal 
assessment was conducted before introducing other 
ports. Window was developed in gastro-colic 
ligament close to greater curvature. Greater 
omentum was released proximally and distally 5 
cm proximal to pylorus with the help of harmonic 
scalpel. 1st endo-stapler with green reload is 
applied and fired at distal stomach apposite crow's 
foot. Orogastric tube of 32 F passed into the 
stomach. Rest of the stomach divided by keeping 
tube as a guide for 30–50 ml of stomach pouch. 
Stapler line was reinforced with sutures (vicryl 
2/0). Orogastric tube was slightly withdrawn and 
blue dye was injected in stomach lumen to ensure 
continuity of staple line. Specimen withdrawn by 
dilating one of the 12 mm port. Patients were 
allowed liquids on 1st post-operative day and were 
discharged within 72 hours post-operatively. 
Weight related calculation include BMI (body 
weight [kg] / height [m2]). 
Excess BMI (preoperative BMI – Ideal 
BMI [85th percentile for gender and age specific 
healthy weight]). 
Percentage excess BMI loss (% EBL) = 
(preoperative BMI – BMI at follow-up / [excess 
BMI] × 100) 
Excess weight =preoperative weight –ideal body 
weight (85th percentile for gender and age specific 
healthy weight]). 
Percentage excess weight loss (% EWL) = 
(preoperative weight – follow-up weight [preoperative 
weight – weight corresponding to the 85th percentile of 
BMI for the patient’s age, gender and height] x 100) 
Success was defined as achieving more than 25% EWL. 
Follow up was at 2weeks, 1, 6 and 12 months. Paired t-
test was used as a test of significance. Statistical analysis 
was performed with SPSS-21.0.  
RESULTS 
A total of 34 patients were included in the study 
over a 6-year period. Among these patients 1 
patient died of sudden cardiac arrest 3 months after 
surgery. Three patients were lost to follow up. 
Data of 30 patients who completed follow up is 
presented here. Females were more common, 
comprising about 24 (80%, n=30), males 6 (20%) 
of study population. Mean age was 39.5±10 (n=30) 
years. In our study participant's minimum BMI 
was 37.1 while maximum BMI was 62.2. There 
were 8 (24%, n=30) patients who fell in the 
category of Superobese (BMI >50). Mean BMI 
was 45.9±6.5 (n=30) at baseline and after 12 
months mean BMI was 36.1±6.3 (p<0.010). 
Average weight of the patients pre-operatively was 
129.9±20.8 kg at base line while average excess 
weight was 70.3±20.8 kg.  
In bariatric surgery weight loss is 
measured in terms of percentage of excess weight 
loss. This simply means weight above ideal body 
weight for patient’s height, weight and gender. 
Mean percentage of excess weight loss after 2 
weeks was 13.5±4.6, at one month 22.0±6.1, at six 
months 37.6±12.0 and at twelve months 47.3±10.1 
as shown in Ttable-1 & figure-2. At twelve month, 
minimum patients lost minimum 34.4% EWL and 
maximum 66.3% EWL%.  
For simple understanding of weight loss, it 
was calculated in terms of kilograms. Average weight 
loss at two weeks was 8.9±2.9 kg, at one month 
14.7±4.6 kg, at 6 months 25.0±7.6 kg and at twelve 
months was 31.4±6.8 kg as shown in figure-3.  
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Figure-1: Port position on the patient 
 
Figure-2: A line chart showing %age of excess 
weight loss during 1 year period 
 
Figure-3: A line chart showing weight loss in Kg 
over time 
Table-1: Weight loss after surgery 
Time Period since 
surgery 
Mean Weight loss 
(Kg) 
Mean Percentage of Excess 
Weight loss (% EWL) 
2 weeks  8.9±2.9 13.5±4.6 
1 month  14.7±4.6 22.0±6.1 
6 months  25.0±7.6 37.6±12.0 
12 months  31.4±6.8 47.3±10.1 
DISCUSSION 
In our study females were about 80% of 
participants. Recent studies suggest morbid obesity 
in on rise in women.18 Another reason for larger 
number of female participants could be a desire to 
attain slim figure for personal, social or 
professional reasons. In women, bariatric surgery 
improves body aches and pains, physical function, 
mental and general health.19 A study showed, 
negative feelings in females may be responsible for 
emotional eating leading to morbid obesity.20 
Mean age in our study was 39.5±10 years while 
mean BMI was 45.8±6.3 kg. Contreras showed that 
patients below age of 45 years lose more weight 
after bariatric surgery than older people.21 A study 
showed that younger women lose more weight as 
compare to elder women after bariatric surgery. A 
study of 489 patients showed younger patient lose 
significant and prolonged BMI decrease over 
time.22 
In our study patient loss on average 47.3% 
of excess weight at one year follow up. Bobowicz 
reported 43.6% of excess weight loss 1 year after 
sleeve gastrectomy which is comparable to our 
results.23 A study of 263 patients showed a median 
percentage of excess weight loss of about 65.7% 
which is much higher than our results.24 This 
difference could be due to inclusion of patient who 
underwent re-sleeve gastrectomy. There are two 
studies which showed percentage of excess weight 
loss of 76.1% and 83.3%.25,26  
Al Zabadi reported a mean weight loss of 
50 kg at one year follow up which is more than 
seen in our study.11 Another study in India showed 
that patients’ body weight decreased significantly 
from a pre-operative of 131.2 to a post-operative 
of 99.4 which is similar to our results 129.9–98.57 
kg at one year follow up.27  
A recently published study showed that at 
one year follow up, %age of excess weight loss is 
higher after sleeve gastrectomy than Roux-en-Y 
gastric bypass.28 A study of 240 patients 
comparing sleeve gastrectomy and Roux-en-Y 
gastric bypass reported that there is no significant 
difference in weight loss and resolution of co-
morbidities at 6 months follow up.29 Previously it 
was thought that gastric bypass surgery produce 
more dramatic weight loss than sleeve 
gastrectomy. Sleeve gastrectomy offer additional 
advantages of short learning curve while providing 
persistent weight loss.30,31 
Bariatric surgery improves cardiovascular 
risk factors, cardiac structure and function, and the 
clinical course of established cardiovascular 
disease.32 Diabetes is well controlled with bariatric 
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surgery than medical therapy alone at one year and 
three years.33 Bariatric surgery not only reduces 
severity of hyperglycaemia but also reduce 
medication requirement for good glycaemic 
control.34  
This is first study in Pakistan on Bariatric 
Surgery and was first experience of the researcher 
to perform independently laparoscopic sleeve 
gastrectomy. This study also has short follow up 
duration. 
CONCLUSION 
Laparoscopic sleeve gastrectomy is an effective 
weight loss surgery with minimal complications. 
On average weight loss of about 30 kg at one year 
was achieved which equals to almost half of excess 
body weight. 
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